𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease

✍ Scribed by Pahwa, Rajesh; Lyons, Kelly E.; Hauser, Robert A.; Fahn, Stanley; Jankovic, Joseph; Pourcher, Emmanuelle; Hsu, Ann; O'Connell, Martin; Kell, Sherron; Gupta, Suneel

Book ID
122334822
Publisher
Elsevier Science
Year
2014
Tongue
English
Weight
897 KB
Volume
20
Category
Article
ISSN
1353-8020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Double-blind trial of levodopa/carbidopa
Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease
✍ Robert A. Hauser; Michel Panisset; Giovanni Abbruzzese; Linda Mancione; Nalina D 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 443 KB

## Abstract We performed a 39‐week, randomized, double‐blind, multicenter study to compare the efficacy, safety, and tolerability of levodopa/carbidopa/entacapone (LCE, Stalevo) with levodopa/carbidopa (LC, Sinemet IR) in patients with early Parkinson's disease (PD). Four hundred twenty‐three patie

Crossover comparison of IPX066 and a sta
Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease
✍ Robert A. Hauser; Aaron L. Ellenbogen; Leo Verhagen Metman; Ann Hsu; Martin J. O 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 359 KB

## Abstract The objective of the study was to compare the pharmacokinetics, motor effects, and safety of IPX066, a novel extended‐release formulation of carbidopa‐levodopa, with an immediate‐release carbidopa‐levodopa formulation in advanced Parkinson's disease. We performed an open‐label crossover